Cargando…

Herpes Simplex Virus 1 MicroRNAs: An Update

BACKGROUND: Herpes simplex virus 1 (HSV-1), an important human pathogen, is capable of latent infection in neurons and productive (lytic) infection in other tissue cells. Once infected with HSV-1, the immune system of the organism cannot eliminate the virus and carries it lifelong. HSV-1 possesses a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duan, Yongzhong, Sun, Le, Li, Qihan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389796/ https://www.ncbi.nlm.nih.gov/pubmed/37285807 http://dx.doi.org/10.1159/000531348

Ejemplares similares

Herpes Simplex Virus 1 Deregulation of Host MicroRNAs
por: Cokarić Brdovčak, Maja, et al.
Publicado: (2018)

Characteristics of herpes simplex virus infection and pathogenesis suggest a strategy for vaccine development
por: Xu, Xingli, et al.
Publicado: (2019)

Herpes Simplex Virus Type 1–Encoded miR-H2-3p Manipulates Cytosolic DNA–Stimulated Antiviral Innate Immune Response by Targeting DDX41
por: Duan, Yongzhong, et al.
Publicado: (2019)

Herpes Simplex Virus Cell Entry Mechanisms: An Update
por: Madavaraju, Krishnaraju, et al.
Publicado: (2021)

Herpes Simplex and Pseudorabies Viruses
por: Hierholzer, Walter J.
Publicado: (1970)

Herpes Simplex Virus 1 Lytic Infection Blocks MicroRNA (miRNA) Biogenesis at the Stage of Nuclear Export of Pre-miRNAs
por: Pan, Dongli, et al.
Publicado: (2019)

Characterization of the Immunologic Phenotype of Dendritic Cells Infected With Herpes Simplex Virus 1
por: Zhang, Jingjing, et al.
Publicado: (2022)

Herpes Simplex Virus Infection in Pregnancy
por: Straface, Gianluca, et al.
Publicado: (2012)

Multifunctional Non-Coding RNAs Mediate Latent Infection and Recurrence of Herpes Simplex Viruses
por: Zhang, Ying, et al.
Publicado: (2021)

Pathogenesis and virulence of herpes simplex virus
por: Zhu, Shuyong, et al.
Publicado: (2021)

A novel bioluminescent herpes simplex virus 1 for in vivo monitoring of herpes simplex encephalitis
por: Uyar, Olus, et al.
Publicado: (2021)

Diagnosis of genital herpes simplex virus infection in the clinical laboratory
por: LeGoff, Jérôme, et al.
Publicado: (2014)

Cellular MicroRNAs 498 and 320d Regulate Herpes Simplex Virus 1 Induction of Kaposi’s Sarcoma-Associated Herpesvirus Lytic Replication by Targeting RTA
por: Yan, Qin, et al.
Publicado: (2013)

Retargeting Strategies for Oncolytic Herpes Simplex Viruses
por: Campadelli-Fiume, Gabriella, et al.
Publicado: (2016)

Immunological control of herpes simplex virus infections
por: Egan, Kevin P., et al.
Publicado: (2013)

Clinical Management of Herpes Simplex Virus Keratitis
por: Labib, Bisant A., et al.
Publicado: (2022)

Antiviral activity of salivary microRNAs for ophthalmic herpes zoster
por: Irmak, M Kemal, et al.
Publicado: (2012)

The interaction of Herpes Simplex Virus with murine lymphocytes. I. Mitogenic properties of herpes simplex virus
Publicado: (1977)

Liver Damage and microRNAs: An Update
por: Cione, Erika, et al.
Publicado: (2022)

The molecular basis of herpes simplex virus latency
por: Nicoll, Michael P, et al.
Publicado: (2012)

Herpes Simplex Virus Type 1 Interactions with the Interferon System
por: Danastas, Kevin, et al.
Publicado: (2020)

The Characteristics of Herpes Simplex Virus Type 1 Infection in Rhesus Macaques and the Associated Pathological Features
por: Fan, Shengtao, et al.
Publicado: (2017)

A Novel Oncolytic Herpes Simplex Virus Design based on the Common Overexpression of microRNA-21 in Tumors
por: Marzulli, M, et al.
Publicado: (2018)

Herpes Simplex Virus Type 2 Is More Difficult to Neutralize by Antibodies Than Herpes Simplex Virus Type 1
por: Silke Heilingloh, Christiane, et al.
Publicado: (2020)

Mucosal Herpes Immunity and Immunopathology to Ocular and Genital Herpes Simplex Virus Infections
por: Chentoufi, Aziz Alami, et al.
Publicado: (2012)

Innate and Adaptive Immune Responses to Herpes Simplex Virus
por: Chew, Tracy, et al.
Publicado: (2009)

Exploiting Herpes Simplex Virus Entry for Novel Therapeutics
por: Hadigal, Satvik, et al.
Publicado: (2013)

Oncolytic Herpes Simplex Virus-Based Therapies for Cancer
por: Aldrak, Norah, et al.
Publicado: (2021)

Herpes simplex virus 1 evades cellular antiviral response by inducing microRNA-24, which attenuates STING synthesis
por: Sharma, Nikhil, et al.
Publicado: (2021)

Attenuated Phenotype and Immunogenic Characteristics of a Mutated Herpes Simplex Virus 1 Strain in the Rhesus Macaque
por: Fan, Shengtao, et al.
Publicado: (2018)

Photodynamic Inactivation of Herpes Simplex Viruses
por: Monjo, Andrea L.-A., et al.
Publicado: (2018)

Oncolytic herpes simplex virus and immunotherapy
por: Ma, Wenqing, et al.
Publicado: (2018)

Chromatin Dynamics during Lytic Infection with Herpes Simplex Virus 1
por: Conn, Kristen L., et al.
Publicado: (2013)

The three-component helicase/primase complex of herpes simplex virus-1
por: Bermek, Oya, et al.
Publicado: (2021)

Current Drugs to Treat Infections with Herpes Simplex Viruses-1 and -2
por: Sadowski, Lauren A., et al.
Publicado: (2021)

Immunopathogenic Role of Herpes Simplex Virus in Behçet's Disease
por: Kim, Do Young, et al.
Publicado: (2013)

Evasion of Early Antiviral Responses by Herpes Simplex Viruses
por: Suazo, Paula A., et al.
Publicado: (2015)

MicroRNAs: An Update of Applications in Forensic Science
por: Rocchi, Anna, et al.
Publicado: (2020)

Latency-Associated Transcript-Derived MicroRNAs in Herpes Simplex Virus Type 1 Target SMAD3 and SMAD4 in TGF-β/Smad Signaling Pathway
por: Shojaei Jeshvaghani, Zahra, et al.
Publicado: (2021)

Are microRNAs Important Players in HIV-1 Infection? An Update
por: Balasubramaniam, Muthukumar, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_89l3fu8kltacvde9hc21kknsc3